Julene Pief, a distinguished scientist of international repute, had developed many successful drugs for a well-established pharmaceutical
Question:
Nevertheless, she had little trouble obtaining an initial investment of $8 million. The Pief
Pharmaceuticals Company was 70% owned by the parent and 30% by Julene. Julene assembled a team of researchers and began operations. By the end of the first year of the life of the new subsidiary, it had expended $3 million on research activities, mostly for researchers’ salaries but also for related research costs.
The subsidiary had developed no marketable products, but Julene and other top executives were extremely pleased with the overall progress and were very optimistic about developing such products within the next 3 or 4 years.
How would you account for the $3 million? Would you write it off as an expense in year 1?
Could it be capitalized as an intangible asset? If so, would you carry it indefinitely? Or would you write it off systematically over 3 years or some longer span? Why?
Fantastic news! We've Found the answer you've been seeking!
Step by Step Answer:
Related Book For
Introduction to Financial Accounting
ISBN: 978-0133251036
11th edition
Authors: Charles Horngren, Gary Sundem, John Elliott, Donna Philbrick
Question Posted: